Screenshot from Forbes' website

Forbes this month announced its 2017 edition of 30 Under 30 Asia list, featuring 300 young innovators, entrepreneurs and leaders who are challenging conventions and making an impact in today’s world.

This is the second year for Forbes to publish the annual list, presenting 30 honorees for each of the 10 categories. SCUT alumnus Luo Ruibang, a 27-year-old genomics researcher, was included in Healthcare & Science, a category identified by the list publisher as a force of young people that are discovering new worlds, in our cells and outer space.

Luo enrolled in SCUT for bioengineering major in 2007, and was admitted to the first enrollment of the SCUT-BGI Genome Science Innovation Class in his second college year. He then started to practice as a genomics researcher at BGI, which is a leading genomic-sequencing institute at Shenzhen where he could learn from some of the world’s most remarkable and experienced scientists.

When he was still an undergraduate student in 2009, he published his research, Building the sequence map of human pan-genome, on Nature Biotechnology as a co-first author. Over the past few years, he has done a series of extraordinary works in genomics that were published on premier international journals such as Science and Nature.

In 2014, Luo cofounded L3 Bioinformatics Limited, a Hong-Kong based company that aims to develop better computing technologies to make the analysis of big genomic data fast, accurate and easy, as well as to realize the value of such data for healthcare. He is currently also a postdoctoral fellow doing research on computational biology at Johns Hopkins University in the US.

From the SCUT News Network